Professor K. C. Nicolaou Speaks at WuXi AppTec
Mar 17, 2009
March 17, 2009 – Shanghai, China – WuXi AppTec (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is honored to have Prof. K. C. Nicolaou, the leading authority of the world on natural product total synthesis, as a WuXi AppTec Science Seminar Series lecturer to share his experience and expertise with our company's scientists today. Total Synthesis is a process of creating complex organic molecules from simpler compounds.
The WuXi AppTec Science Seminar Series is a monthly program that invites the world's top scientific minds and leaders in the pharmaceutical industry to speak with our company's scientists. The program aims to keep them informed about the latest developments in a broad range of topics in pharmaceutical research and development.
Dr. Nicolaou received his Ph.D. from University College London in 1972. From 1972 to 1976, he conducted postdoctoral research, first under Professor T.J. Katz of Columbia University and later under Professor E.J. Corey of Harvard University. He then joined the faculty at the University of Pennsylvania, where he became the Rhodes-Thompson Professor of Chemistry. In 1989, he accepted joint appointments at the University of California, San Diego, where he is Professor of Chemistry, and at the Scripps Research Institute, where he is the Chairman of the Department of Chemistry and holds the Skaggs Professorship of Chemical Biology and the Darlene Shiley Chair in Chemistry.
Dr. Nicolaou is a member of the New York Academy of Sciences, a fellow of the American Academy of Arts and Sciences, a member of the National Academy of Sciences, a fellow of the American Association for the Advancement of Science, and a foreign member of the Academy of Athens. He holds numerous honorary degrees from leading universities. He is author or co-author of more than 60 patents, more than 675 publications, and four books, including textbooks on total synthesis.
"I'm especially pleased to have Dr. Nicolaou here in Shanghai to share his knowledge of organic synthesis," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "WuXi AppTec is one of the largest employers of synthetic chemists in the world. We will apply the messages in his lecture to our efforts to produce bioactive molecules for the world's leading pharmaceutical companies."
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.